• Explore /
  • Poster
  • / Polymorphisms as markers of sunitinib efficacy and toxicity in first-line treatment of renal clear cell carcinoma: Final results of a multicentric prospective study by the Spanish Oncology Genitourinary Group.

Polymorphisms as markers of sunitinib efficacy and toxicity in first-line treatment of renal clear cell carcinoma: Final results of a multicentric prospective study by the Spanish Oncology Genitourinary Group.

Abstract Poster

Authors

null

J. Garcia-Donas

Hospital Universitario Fundación Alcorcón, Alcorcon, Spain

J. Garcia-Donas , E. Esteban , L. J. Leandro-García , D. E. Castellano , A. Gonzalez del Alba , M. A. Climent , J. A. Arranz , E. Gallardo , J. Puente , J. Bellmunt , B. Mellado , E. Martínez , F. Moreno , A. Font , M. Robledo , C. Rodriguez de Antona

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer

Sub Track

Kidney Cancer

Citation

J Clin Oncol 29: 2011 (suppl; abstr 4559)

Abstract #

4559

Poster Bd #

14

Abstract Disclosures

Similar Posters

First Author: Enrique Grande

First Author: Yuksel Urun

Poster

2013 ASCO Annual Meeting

Association analysis of polymorphisms in genes related to sunitinib pharmacokinetics.

Association analysis of polymorphisms in genes related to sunitinib pharmacokinetics.

First Author: Meta Diekstra

First Author: Gerard A. Milano